Nuveen Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-42,473
| Closed | -$1.83M | – | 3425 |
|
|
2024
Q1 | $1.83M | Buy |
42,473
+2,109
| +5% | +$90.8K | ﹤0.01% | 2443 |
|
|
2023
Q4 | $1.86M | Sell |
40,364
-1,331
| -3% | -$61.3K | ﹤0.01% | 2444 |
|
|
2023
Q3 | $1.42M | Buy |
41,695
+1,496
| +4% | +$51.1K | ﹤0.01% | 2432 |
|
|
2023
Q2 | $1.55M | Sell |
40,199
-13,108
| -25% | -$505K | ﹤0.01% | 2460 |
|
|
2023
Q1 | $1.91M | Buy |
53,307
+2,027
| +4% | +$72.6K | ﹤0.01% | 2352 |
|
|
2022
Q4 | $2.02M | Buy |
51,280
+920
| +2% | +$36.3K | ﹤0.01% | 2383 |
|
|
2022
Q3 | $1.82M | Buy |
50,360
+6,049
| +14% | +$218K | ﹤0.01% | 2443 |
|
|
2022
Q2 | $1.35M | Sell |
44,311
-5,486
| -11% | -$167K | ﹤0.01% | 2647 |
|
|
2022
Q1 | $1.57M | Buy |
49,797
+7,913
| +19% | +$249K | ﹤0.01% | 2623 |
|
|
2021
Q4 | $1.31M | Buy |
41,884
+12,586
| +43% | +$393K | ﹤0.01% | 2758 |
|
|
2021
Q3 | $448K | Sell |
29,298
-24,156
| -45% | -$369K | ﹤0.01% | 3186 |
|
|
2021
Q2 | $995K | Buy |
53,454
+35,811
| +203% | +$667K | ﹤0.01% | 3009 |
|
|
2021
Q1 | $316K | Buy |
17,643
+5,043
| +40% | +$90.3K | ﹤0.01% | 3165 |
|
|
2020
Q4 | $194K | Buy |
+12,600
| New | +$194K | ﹤0.01% | 3201 |
|